Follow CGSP on Social Media

Listen to the CGSP Podcast

With the COVID Crisis Exploding in India, More Countries Turn to China to Fill the Vaccine Void

by Eric Olander
People walk past notices announcing that the Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine is out of stock at a vaccination centre in Mumbai on April 20, 2021 amidst rising Covid-19 coronavirus cases. INDRANIL MUKHERJEE / AFP

The vaccine distribution dynamic is rapidly changing in response to the unfolding calamity in India, where the country’s healthcare system has collapsed due to an explosion of infections across the country.

Experts say the Indian government’s claim of 300,000 infections and 2,000 deaths per day is a severe undercount because the pandemic is spreading fastest in the countryside where there’s no way to monitor it due to a lack of public health infrastructure.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

OR

Already a subscriber? Log in Click Here to Learn More

You Might Like

This Graphic Shows the Huge Diplomatic Opportunity For China If It Can Provide Africa With Sufficient Supplies of C19 Vaccines

It is becoming increasingly apparent that Africa is going to be the last region around the world to secure sufficient supplies of COVID-19 vaccines to innoculate a majority of its population, according to ...

If/When Two Chinese COVID-19 Vaccines Get Approval From WHO, Demand From Developing Countries Likely to Increase

Two Chinese-made COVID-19 vaccines made by Sinopharm and Sinovac are now under evaluation by the World Health Organization to receive the highly prized prequalification (PQ) status. If the Chinese vaccines do receive WHO ...

COVID Wave Drives Chinese Consumers to Indian Generics

As the BF7 Omicron variant pushes China’s public health care system to its limits, the country is running out of antiviral medications like Pfizer’s Paxlovid. These shortages seem to be driving ...

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

Subscribe